Trademark: FARXIGA
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for FARXIGA
We do not have any records of a proof of use for FARXIGA at this moment.
Possible trademark infringements of FARXIGA
Basic Information about FARXIGA
- Serial Number
- 86049285
- Filing Date
- 27 Aug 2013
- Registration Number
- 4638205
- Registration Date
- 11 Nov 2014
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of FARXIGA on the blockchain with WikiTrademarks.io.
- First use of FARXIGA anywhere
- FARXIGA was first used on 21 Jan 2014 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns FARXIGA?
1. ASTRAZENECA AB Södertälje
2. ASTRAZENECA AB SODERTALJE
3. Bristol-Myers Squibb Company New York NY
4. Bristol-Myers Squibb Company New York NY
Correspondent
- Cara M. Kearney
- AstraZeneca Pharmaceuticals LP
- 1800 Concord Pike, A2C
- Wilmington DE 19850-5437
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io